Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Breast Neoplasms 10 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 5 Head and Neck Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Squamous Cell 5 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Prostatic Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 Hematologic Neoplasms 2 Glioma 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unilateral HER2 Positive Breast Cancer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Cancers of the Head and Neck 1 Solid Tumors 1

Interventions

Temozolomide 73 Bevacizumab 57 Radiotherapy 40 Radiosurgery 28 Carboplatin 23 Nivolumab 17 Etoposide 17 Cisplatin 17 pembrolizumab 16 Irinotecan 16 Ipilimumab 15 Magnetic Resonance Spectroscopy 14 Erlotinib Hydrochloride 14 Cyclophosphamide 14 Carmustine 14 Pemetrexed 13 Topotecan 10 Surgical Procedures, Operative 10 Capecitabine 10 Lapatinib 9 Filgrastim 9 Trastuzumab 8 Thalidomide 8 Sunitinib 8 Paclitaxel 8 Lomustine 8 Aminolevulinic Acid 8 encorafenib 7 binimetinib 7 Vincristine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Afatinib × Clear all

NCT04158947 2020-05-12

HER2BAT

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡